CEO of RHeoGene. Started the company in 1999 as a JV between Rohm & Haas and Argonex. In 2003, he led the highly innovative and unique effort to donate the IP and material assets of RHeoGene to the UPMC. As RheoGene CEO, he and his team established an innovative clinical development program with the RheoSwitch® Therapeutic System (RTS) that has led to the first human clinical trial of a small molecule-induced gene regulation system.

Founder & VP Marketing and Communications @ RheoGene
Co-founder Immunotope
Portfolio Manager, Biostrategy Partners
Rohm and Haas Co.

CEO at Prairie Diagnostic Services, Inc., a full service veterinary diagnostic laboratory
Chief Medical Officer at Premune
Schering-Plough Animal Health, Pfizer AH (international HQ), Intervet, Inc., Baxter HealthCare and Merial
DVM from Cornell University

President of Amlan International the Animal Health and Nutrition Division of family owned publicly traded sorbent mineral company from Chicago, Illinois.
NOVARTIS ANIMAL VACCINES INC., President & CEO
PFIZER ANIMAL HEALTH Marketing Director/Senior Marketing Manger, Global Biologicals
SMITHKLINE BEECHAM ANIMAL HEALTH Director, Worldwide Strategic Product Development